DE602004015970D1 - Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure - Google Patents

Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure

Info

Publication number
DE602004015970D1
DE602004015970D1 DE602004015970T DE602004015970T DE602004015970D1 DE 602004015970 D1 DE602004015970 D1 DE 602004015970D1 DE 602004015970 T DE602004015970 T DE 602004015970T DE 602004015970 T DE602004015970 T DE 602004015970T DE 602004015970 D1 DE602004015970 D1 DE 602004015970D1
Authority
DE
Germany
Prior art keywords
fatty acid
metabolic
inclusion
tissue
blood flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004015970T
Other languages
German (de)
English (en)
Inventor
David R Elmaleh
Alan J Fischman
Timothy M Shoup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of DE602004015970D1 publication Critical patent/DE602004015970D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602004015970T 2003-04-17 2004-04-19 Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure Expired - Lifetime DE602004015970D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46357403P 2003-04-17 2003-04-17
PCT/US2004/012084 WO2004093650A2 (en) 2003-04-17 2004-04-19 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid

Publications (1)

Publication Number Publication Date
DE602004015970D1 true DE602004015970D1 (de) 2008-10-02

Family

ID=33310796

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004015970T Expired - Lifetime DE602004015970D1 (de) 2003-04-17 2004-04-19 Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure

Country Status (9)

Country Link
US (9) US7494642B2 (https=)
EP (1) EP1622602B1 (https=)
JP (1) JP4633052B2 (https=)
AT (1) ATE405258T1 (https=)
AU (1) AU2004232297B2 (https=)
CA (1) CA2522737C (https=)
DE (1) DE602004015970D1 (https=)
MX (1) MXPA05011189A (https=)
WO (1) WO2004093650A2 (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4272259B2 (ja) * 1995-12-01 2009-06-03 モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド 診断用イメージングのための脂肪酸アナログの立体異性体
US8565860B2 (en) 2000-08-21 2013-10-22 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system
US8489176B1 (en) 2000-08-21 2013-07-16 Spectrum Dynamics Llc Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
US8909325B2 (en) 2000-08-21 2014-12-09 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
WO2004093650A2 (en) 2003-04-17 2004-11-04 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
US8586932B2 (en) 2004-11-09 2013-11-19 Spectrum Dynamics Llc System and method for radioactive emission measurement
US9470801B2 (en) 2004-01-13 2016-10-18 Spectrum Dynamics Llc Gating with anatomically varying durations
US10964075B2 (en) 2004-01-13 2021-03-30 Spectrum Dynamics Llc Gating with anatomically varying durations
CN1981210A (zh) 2004-01-13 2007-06-13 光谱动力学有限责任公司 多维图像重构
US9040016B2 (en) 2004-01-13 2015-05-26 Biosensors International Group, Ltd. Diagnostic kit and methods for radioimaging myocardial perfusion
US8571881B2 (en) 2004-11-09 2013-10-29 Spectrum Dynamics, Llc Radiopharmaceutical dispensing, administration, and imaging
EP1778957A4 (en) 2004-06-01 2015-12-23 Biosensors Int Group Ltd OPTIMIZING THE MEASUREMENT OF RADIOACTIVE RADIATION ON SPECIAL BODY STRUCTURES
US8606349B2 (en) 2004-11-09 2013-12-10 Biosensors International Group, Ltd. Radioimaging using low dose isotope
US8423125B2 (en) 2004-11-09 2013-04-16 Spectrum Dynamics Llc Radioimaging
US9943274B2 (en) 2004-11-09 2018-04-17 Spectrum Dynamics Medical Limited Radioimaging using low dose isotope
US10136865B2 (en) 2004-11-09 2018-11-27 Spectrum Dynamics Medical Limited Radioimaging using low dose isotope
US8615405B2 (en) 2004-11-09 2013-12-24 Biosensors International Group, Ltd. Imaging system customization using data from radiopharmaceutical-associated data carrier
US9316743B2 (en) 2004-11-09 2016-04-19 Biosensors International Group, Ltd. System and method for radioactive emission measurement
WO2008059489A2 (en) 2006-11-13 2008-05-22 Spectrum Dynamics Llc Radioimaging applications of and novel formulations of teboroxime
US8837793B2 (en) 2005-07-19 2014-09-16 Biosensors International Group, Ltd. Reconstruction stabilizer and active vision
US8644910B2 (en) 2005-07-19 2014-02-04 Biosensors International Group, Ltd. Imaging protocols
GB0525949D0 (en) * 2005-12-21 2006-02-01 Hammersmith Imanet Ltd Pet radiotracers
US20090177098A1 (en) * 2006-01-16 2009-07-09 Kousuke Yakubo Examination System and Examination Method
US8894974B2 (en) 2006-05-11 2014-11-25 Spectrum Dynamics Llc Radiopharmaceuticals for diagnosis and therapy
WO2008075362A2 (en) 2006-12-20 2008-06-26 Spectrum Dynamics Llc A method, a system, and an apparatus for using and processing multidimensional data
US8521253B2 (en) 2007-10-29 2013-08-27 Spectrum Dynamics Llc Prostate imaging
AU2010246010A1 (en) * 2009-05-04 2011-11-17 Washington University PET radiotracers for imaging fatty acid metablolism and storage
WO2010144876A1 (en) * 2009-06-12 2010-12-16 University Of Louisville Research Foundation, Inc Methods to detect cancer in animals
US8338788B2 (en) 2009-07-29 2012-12-25 Spectrum Dynamics Llc Method and system of optimized volumetric imaging
US20110110570A1 (en) * 2009-11-10 2011-05-12 Avi Bar-Shalev Apparatus and methods for generating a planar image
DE102010010666A1 (de) * 2010-03-01 2011-09-01 Sven Reske Diagnose und Therapie von Krebserkrankungen mittels Fettsäuren
CN105517492B (zh) * 2013-09-06 2019-10-18 皇家飞利浦有限公司 用于处理心脏数据的处理设备
JP2019534284A (ja) * 2016-11-08 2019-11-28 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 臨床設定用［ｆ−１８］ｆｄｄｎｐの複数ドーズ合成方法
CN108727229B (zh) * 2017-04-17 2021-07-02 北京先通国际医药科技股份有限公司 一种修饰脂肪酸型pet试剂前体的新工艺路线
KR102718221B1 (ko) * 2018-07-20 2024-10-15 아스텔라스세이야쿠 가부시키가이샤 양전자 방출 핵종으로 표지된 지방산 유도체
JP7652084B2 (ja) * 2020-01-17 2025-03-27 アステラス製薬株式会社 陽電子放出核種で標識された脂肪酸誘導体
CN114700006B (zh) * 2022-06-07 2023-03-24 北京先通国际医药科技股份有限公司 一种液体组合物的生产设备及其制备方法和用途
CN114732918B (zh) * 2022-06-10 2022-09-13 北京先通国际医药科技股份有限公司 一种液体组合物的生产设备及其制备方法和用途
CN114736112A (zh) * 2022-06-14 2022-07-12 北京先通国际医药科技股份有限公司 一种心肌代谢pet显像剂的制备方法及用途
CN114796534B (zh) * 2022-06-23 2022-09-16 北京先通国际医药科技股份有限公司 包含化合物ⅰ的液体组合物、制备方法及用途
CN114773179B (zh) * 2022-06-23 2022-09-16 北京先通国际医药科技股份有限公司 一种化合物ⅰ液体组合物的制备方法、及其在心肌代谢pet显像上的用途
CN115181013B (zh) * 2022-07-22 2023-08-08 北京先通国际医药科技股份有限公司 修饰脂肪酸型pet试剂前体关键中间体的制备方法及其用途
CN115959978B (zh) * 2022-07-22 2024-08-13 北京先通国际医药科技股份有限公司 一种修饰长链脂肪酸型pet试剂前体的合成方法及其用途
CN115141087B (zh) * 2022-09-06 2023-03-24 北京先通国际医药科技股份有限公司 Pet前体关键中间体的异构体的合成方法及其用途
CN115970012A (zh) * 2023-03-16 2023-04-18 北京先通国际医药科技股份有限公司 正电子心肌脂肪酸代谢显像剂与正电子18f-fdg心肌葡萄糖显像剂用于pet联合显像的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119640A (en) * 1975-07-10 1978-10-10 Union Carbide Corporation Polymerizable epoxide-modified compositions
DE2828623C2 (de) * 1978-06-29 1983-11-17 Kernforschungsanlage Jülich GmbH, 5170 Jülich Mit radioaktivem Flour markierte C↓1↓↓6↓-bis C↓1↓↓8↓- Fettsäuren, ein Verfahren zu ihrer Herstellung sowie deren Verwendung
US4202902A (en) * 1979-03-05 1980-05-13 Shell Oil Company Lipogenesis control by cyclopropane-carboxylic acids, esters and amides
US4524059A (en) * 1983-01-28 1985-06-18 The General Hospital Corporation Fatty acid analogs
US4933365A (en) * 1989-01-25 1990-06-12 American Home Products Corporation Phospholipase A2 inhibitors
DE4012405C1 (en) * 1990-04-19 1991-08-14 Forschungszentrum Juelich Gmbh, 5170 Juelich, De Radioisotope labelled oxiranyl carboxylic acid derivs. prodn. - by nucleophilic replacement of corresp. bromo or iodo substits. with radioactive alkali halide(s) in polar medium
JP4272259B2 (ja) * 1995-12-01 2009-06-03 モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド 診断用イメージングのための脂肪酸アナログの立体異性体
IT1295658B1 (it) * 1997-09-29 1999-05-24 Menarini Ricerche Spa Composizioni farmaceutiche contenenti acido ricinoleico e loro uso per la terapia antifiammatoria ed analgesica
AU778834B2 (en) * 1999-04-14 2004-12-23 Molecular Insight Pharmaceuticals, Inc. Fatty acid analogs for diagnosis of coronary artery disease
WO2004092184A1 (de) * 2003-04-12 2004-10-28 Forschungszentrum Rossendorf E.V. Technetiummarkierte fettsäuren und deren verwendung für die myokarddiagnostik sowie verfahren zur herstellung der technetiummarkierten fettsäuren
WO2004093650A2 (en) * 2003-04-17 2004-11-04 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
US8345063B2 (en) * 2008-04-04 2013-01-01 Advanced Micro Devices, Inc. Filtering method and apparatus for anti-aliasing

Also Published As

Publication number Publication date
US7790142B2 (en) 2010-09-07
US20090156848A1 (en) 2009-06-18
US8309053B2 (en) 2012-11-13
US20080214853A1 (en) 2008-09-04
JP2006524250A (ja) 2006-10-26
ATE405258T1 (de) 2008-09-15
US20080095702A1 (en) 2008-04-24
WO2004093650A3 (en) 2005-04-14
MXPA05011189A (es) 2006-05-25
AU2004232297A1 (en) 2004-11-04
US7494642B2 (en) 2009-02-24
US20130052129A1 (en) 2013-02-28
CA2522737A1 (en) 2004-11-04
JP4633052B2 (ja) 2011-02-16
EP1622602B1 (en) 2008-08-20
US20080206135A1 (en) 2008-08-28
US8268291B2 (en) 2012-09-18
US20040253177A1 (en) 2004-12-16
HK1083414A1 (en) 2006-06-30
US20080213178A1 (en) 2008-09-04
CA2522737C (en) 2017-06-06
EP1622602A4 (en) 2006-06-21
US20080214851A1 (en) 2008-09-04
US20080213173A1 (en) 2008-09-04
EP1622602A2 (en) 2006-02-08
WO2004093650A2 (en) 2004-11-04
US8871179B2 (en) 2014-10-28
AU2004232297B2 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
DE602004015970D1 (de) Verfahren zur überwachung des blutflusses und der metabolischen aufnahme in gewebe mit radioaktiv markierter alkansäure
EA200802213A1 (ru) Способы лечения заболеваний крови
EA200501322A1 (ru) Органические соединения железа (iii), их применение и способы получения указанных соединений
DK1660528T3 (da) Mutein af tåre-lipocalin
DE602005020269D1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
UA88491C2 (ru) Способ очищения транс-(-)-δ9-тетрагидроканабинола и транс-(+)-δ9-тетрагидроканабинола (варианты)
ATE526401T1 (de) Verfahren zur herstellung von proteinen mit freien cysteinresten
AR002241A1 (es) Derivado de 2,4-oxazolidinadiona, composicion farmaceutica que lo comprende y metodo de preparacion del mismo.
EA200401540A1 (ru) Спироиндолинпиперидиновые производные
PE20061397A1 (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos productos y metodos de preparacion
BRPI0510623A (pt) compostos de derivados de prolina e morfolina
DK1812076T3 (da) Blodpladeafledte vækstfaktorsammensætninger og fremgangsmåder til anvendelse heraf
BRPI0508098A (pt) compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos
EA200602077A1 (ru) Активируемые частицы, их получение и применение
DE60335552D1 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
BRPI0410979A (pt) composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia
AR033957A1 (es) Nuevos compuestos
EA200200232A1 (ru) Интерлейкин-5 ингибирующие производные 6-азаурацила
ATE400272T1 (de) Piperidin-verbindungen als malonyl-coa decarboxylase-hemmer
DK1360178T3 (da) Hidtil ukendte heterocykliske analoger af diphenylethylenforbindelser
BRPI0417167A (pt) composições para animais de estimação compreendendo oligofrutose de cadeia curta
ATE345340T1 (de) N-substituierte-1h-indol-5-propansäure verbindungen als ppar-agonisten zur behandlung von diabetis
TR200100125T2 (tr) Çok döngülü tiyazolidin-2-iliden aminleri, bunların üretimi için yöntemler
EA200500473A1 (ru) Эритропоэтины длительного действия, которые сохраняют тканезащитную активность эндогенного эритропоэтина
BRPI0417179A (pt) gentisato de amlodipina, método de preparar o mesmo e composição farmacêutica para tratamento de doenças cardiovasculares

Legal Events

Date Code Title Description
8364 No opposition during term of opposition